Kinaxo Biotechnologies

Saarwellingen, Germany Founded: 2005 • Age: 21 yrs Acquired By Evotec
Chemical proteomics for cellular target profiling and drug discovery services

About Kinaxo Biotechnologies

Kinaxo Biotechnologies is a company based in Saarwellingen (Germany) founded in 2005 was acquired by Evotec in February 2011.. Kinaxo Biotechnologies has raised $1.38 million across 4 funding rounds from investors including Evotec, Max-Planck-Gesellschaft and KfW. Kinaxo Biotechnologies operates in a competitive market with competitors including Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others.

  • Headquarter Saarwellingen, Germany
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $1.38 M (USD)

    in 4 rounds

  • Latest Funding Round
  • Investors
    Evotec

    & 7 more

  • Employee Count
    Employee Count
  • Acquired by
    Evotec

    (Feb 09, 2011)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Kinaxo Biotechnologies

Kinaxo Biotechnologies has successfully raised a total of $1.38M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round
  • First Round

    (16 Jul 2007)

  • Investors Count 7
Date Amount Transaction Name Valuation Lead Investors Investors
Nov, 2009 Amount Series A - Kinaxo Biotechnologies Valuation Mountain Partners , Max-Planck-Gesellschaft
Feb, 2009 Amount Grant - Kinaxo Biotechnologies Valuation

investors

Jul, 2008 Amount Grant - Kinaxo Biotechnologies Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Kinaxo Biotechnologies

Kinaxo Biotechnologies has secured backing from 8 investors, including venture fund and institutional investors. Prominent investors backing the company include Evotec, Max-Planck-Gesellschaft and KfW. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Global tech investments are made by venture capital firm.
Founded Year Domain Location
Early-stage investments are made in high-tech startups by HTGF.
Founded Year Domain Location
Ombudsman services for scientific misconduct in research are provided confidentially.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Kinaxo Biotechnologies

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Kinaxo Biotechnologies

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Kinaxo Biotechnologies Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Kinaxo Biotechnologies

Kinaxo Biotechnologies operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nautilus Biotechnology, Somalogic, ProteinSimple, Amunix and Dynamic Biosensors, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
A proteomics platform is developed for analyzing the human proteome.
domain founded_year HQ Location
Protein-based assays are developed for life science research.
domain founded_year HQ Location
Provider tools to help researchers with protein analysis
domain founded_year HQ Location
Peptide-based therapeutics are developed for cancers and immune disorders.
domain founded_year HQ Location
Label-free solutions for molecular interactions and biophysical analysis are provided.
domain founded_year HQ Location
Proteomics services are delivered via discovery and targeted platforms.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Kinaxo Biotechnologies

Frequently Asked Questions about Kinaxo Biotechnologies

When was Kinaxo Biotechnologies founded?

Kinaxo Biotechnologies was founded in 2005 and raised its 1st funding round 2 years after it was founded.

Where is Kinaxo Biotechnologies located?

Kinaxo Biotechnologies is headquartered in Saarwellingen, Germany. It is registered at Saarwellingen, Saarland, Germany.

Is Kinaxo Biotechnologies a funded company?

Kinaxo Biotechnologies is a funded company, having raised a total of $1.38M across 4 funding rounds to date. The company's 1st funding round was a Grant of $792.27K, raised on Jul 16, 2007.

What does Kinaxo Biotechnologies do?

Kinaxo Biotechnologies was established in 2005 as a spin-off from the Max Planck Institute of Biochemistry in Martinsried, Germany. Operations are focused on chemical proteomics methods to aid small molecule drug development. Services include cellular target profiling and related applications, developed in collaboration with Max Planck laboratories. The company is based in Saarwellingen, Germany, and was acquired by Evotec in February 2011.

Who are the top competitors of Kinaxo Biotechnologies?

Kinaxo Biotechnologies's top competitors include Somalogic, Nautilus Biotechnology and Elektrofi.

Who are Kinaxo Biotechnologies's investors?

Kinaxo Biotechnologies has 8 investors. Key investors include Evotec, Max-Planck-Gesellschaft, KfW, BMBF, and Bayerisches Landesportal.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available